08
October 2024
Past Event
Do Drug Patents Cause High Drug Prices?

Event will air on this page.

 

Inquiries: [email protected]

Do Drug Patents Cause High Drug Prices?

Past Event
Online Only
October 08, 2024
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
Caption
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
08
October 2024
Past Event

Event will air on this page.

 

Inquiries: [email protected]

Speakers:
Adam Mossoff
Adam Mossoff

Chair, Forum for Intellectual Property and Senior Fellow

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law
Erika Lietzan

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law

Vice President and Global Head of Intellectual Property Affairs, Novartis
Corey A. Salsberg

Vice President and Global Head of Intellectual Property Affairs, Novartis

Moderator:
hartline
Devlin Hartline

Senior Fellow

For the past decade, policy activists have argued that drug innovators artificially extend the length of their exclusive patent protections on their drugs solely to keep drug prices high. One activist organization, the Initiative for Medicines, Access, and Knowledge (I-MAK), alleges that as many as 50 patents currently protect drugs from generic competition. 

But are I-MAK’s patent numbers correct? A 2022 Hudson policy memo, “How Unreliable Data Has Infected the Policy Debate Over Drug Patents,”detailed how I-MAK’s patent numbers contradict the number of drug patents listed in the Orange Book, the Food and Drug Administration’s official database of drug patents. Academic scholars have also done rigorous empirical studies, and the United States Patent and Trademark Office (USPTO) released its own empirical study in June 2024. Neither the USPTO nor the academic studies could replicate or confirm activist organizations’ patent numbers. Yet I-MAK’s claims continue to drive legislative proposals and agency actions.

Join Hudson for an expert discussion on the state of play concerning the empirical evidence on the connection between drug patents and drug prices and whether officials are engaging in evidence-based policymaking on this pressing concern.

Related Events
07
October 2025
In-Person Event | Hudson Institute
Understanding China’s Political and Institutional Foundations: A Conversation with Chenggang Xu
Featured Speakers:
Professor Chenggang Xu
Getty Images
07
October 2025
In-Person Event | Hudson Institute
Understanding China’s Political and Institutional Foundations: A Conversation with Chenggang Xu

Join Dr. Miles Yu, senior fellow and director of Hudson’s China Center, for a conversation with Professor Xu on why misunderstanding China’s political order may create critical strategic risks for the US amid intensifying geopolitical rivalry.

Getty Images
Featured Speakers:
Professor Chenggang Xu
08
October 2025
In-Person Event | Hudson Institute
Relearning Great Power Diplomacy: A Conversation with Wess Mitchell
Featured Speakers:
Wess Mitchell
A detail photo of “A Peace Conference at the Quai d'Orsay” by William Orpen. (Wikimedia Commons)
08
October 2025
In-Person Event | Hudson Institute
Relearning Great Power Diplomacy: A Conversation with Wess Mitchell

Join Hudson’s Peter Rough for a discussion with Wess Mitchell on the future of great power diplomacy.

A detail photo of “A Peace Conference at the Quai d'Orsay” by William Orpen. (Wikimedia Commons)
Featured Speakers:
Wess Mitchell
15
October 2025
In-Person Event | Hudson Institute
Vanguard of Manufacturing: Fortifying US National Security
Featured Speakers:
John Maslin
Austin Grey
Hon. Peter J. F. Meijer
Patrick Hunt
Julius Krein
Moderator:
Getty Images
15
October 2025
In-Person Event | Hudson Institute
Vanguard of Manufacturing: Fortifying US National Security

Join Hudson Institute for a conference on the future of America’s industrial base.

Getty Images
Featured Speakers:
John Maslin
Austin Grey
Hon. Peter J. F. Meijer
Patrick Hunt
Julius Krein
Moderator:
16
October 2025
In-Person Event | Hudson Institute
CCP Committee Chairman John Moolenaar on the State of US-China Relations
Featured Speakers:
Congressman John Moolenaar
Getty Images
16
October 2025
In-Person Event | Hudson Institute
CCP Committee Chairman John Moolenaar on the State of US-China Relations

Congressman John Moolenaar (R-MI), chairman of the House Select Committee on the CCP, will join Hudson Senior Fellow David Feith to discuss how Washington should approach the US-China relationship in an era of rising geopolitical competition.

Getty Images
Featured Speakers:
Congressman John Moolenaar